Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 45 Information Technology 40 Financials 26 Industrials 23 Consumer Discretionary 6 Communication Services 5 Consumer Staples 4 Utilities 4 Materials 3 Energy 2 Real Estate 1

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 16 Healthcare Equipment & Supplies 11 Healthcare Providers & Services 9 Pharmaceuticals 7 Life Sciences Tools & Services 2
Curated industry list

Rapid Revenue Growth in Biotechnology on NASDAQ

Explore Rapid Revenue Growth in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Alnylam Pharmaceuticals Inc (ALNY)
Fair Value9.1% Upside Fair Analyst71.7% Upside Market Cap29.331 B P/E38.2x Yield0.0% HealthGood
  NASDAQ Featured in Rapid Revenue Growth
Compugen Ltd (CGEN)
Fair Value23.6% Upside Undervalued Analyst92.5% Upside Market Cap228.3 M P/E6.4x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth
Halozyme Therapeutics Inc (HALO)
Fair Value7.9% Upside Fair Analyst-2.9% Downside Market Cap11.704 B P/E28.4x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Insmed Inc (INSM)
Fair Value-16.3% Downside Fair Analyst51.1% Upside Market Cap28.63 B P/E-32.7x Yield0.0% HealthFair
  NASDAQ Featured in Rapid Revenue Growth
MannKind Corp (MNKD)
Fair Value16.7% Upside Fair Analyst99.0% Upside Market Cap1.322 B P/E-30.0x Yield0.0% HealthFair
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks Small-Cap Stocks
Neurocrine Biosciences Inc (NBIX)
Fair Value24.1% Upside Undervalued Analyst31.0% Upside Market Cap16.61 B P/E23.6x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Rigel Pharmaceuticals Inc (RIGL)
Fair Value13.7% Upside Fair Analyst37.3% Upside Market Cap750.4 M P/E2.3x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Vericel Corp Ord (VCEL)
Fair Value18.5% Upside Undervalued Analyst37.5% Upside Market Cap2.309 B P/E93.6x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Aurinia Pharmaceuticals Inc (AUPH)
Fair Value-42.5% Downside Overvalued Analyst9.5% Upside Market Cap2.109 B P/E6.7x Yield0.0% HealthExcellent
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth High-Growth Small-Cap Stocks Small-Cap Stocks
Genmab AS (GMAB)
Fair Value38.5% Upside Undervalued Analyst25.1% Upside Market Cap18.447 B P/E23.3x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
TG Therapeutics Inc (TGTX)
Fair Value25.1% Upside Undervalued Analyst57.5% Upside Market Cap7.058 B P/E15.9x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Travere Therapeutics Inc (TVTX)
Fair Value2.6% Upside Fair Analyst18.3% Upside Market Cap5.78 B P/E-85.7x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Argenx NV ADR (ARGX)
Fair Value8.1% Upside Fair Analyst22.9% Upside Market Cap55.152 B P/E31.9x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Kiniksa Pharmaceuticals Ltd (KNSA)
Fair Value-5.2% Downside Fair Analyst27.6% Upside Market Cap5.935 B P/E74.4x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Momentum Stocks
Nanobiotix (NBTX)
Fair Value-28.9% Downside Overvalued Analyst21.6% Upside Market Cap1.961 B P/E-68.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth
Telix Pharmaceuticals Ltd ADR (TLX)
Fair Value-14.6% Downside Fair Analyst78.9% Upside Market Cap3.993 B P/E-575.7x Yield0.0% HealthGood
  NASDAQ Featured in Rapid Revenue Growth
Explore listed stocks on NASDAQ with company information and fair value data.